-
Mashup Score: 0Quintuple Regimen Prolongs PFS in Advanced, High-Grade Epithelial Ovarian Cancer +/- BRCA Mutations - 1 year(s) ago
In the phase 3 DUO-O study, combing 5 targeted and chemotherapy agents for the treatment of newly diagnosed, advanced, high-grade epithelial ovarian cancer with or without BRCA mutations has shown to extend progression-free survival.
Source: Targeted OncologyCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 36
A randomized trial in treatment-naive patients with metastatic renal cell carcinoma shows that the addition of a live bacterial product to an immunotherapy combination elicits promising clinical benefit in association with an enrichment of bacterial species, circulating cytokines and immune cell populations in responders.
Source: NatureCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 27
La Generalitat pagará los tratamientos para dejar el tabaco de las personas con rentas más bajas
Source: abcCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Reddip - 2 year(s) ago
Directorio de recursos digitales para investigación y publicación científica
Source: Yep.soCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1I JORNADA ONCOHEMATOGERIATRIA - 3 year(s) ago
Formato virtualRetransmisión en streaming* Fechas: 23 de Septiembre de 2021 16:00 a 19:45 h 24 de Septiembre de 2021 09:00 a 13:00 h y 16:00 a 18:30 h *Para participantes registrados Objetivos: Conocer las características principales y revisar las novedades terapéuticas de los procesos…
Source: live.ohg2021.comCategories: Latest Headlines, Oncologists2Tweet
Quintuple Regimen Prolongs PFS in Advanced, High-Grade Epithelial Ovarian Cancer +/- BRCA Mutations https://t.co/org12ENjBk vía @targetedonc. Good news for our patients! Cant wait to see the value of Durvalumab to the combination! @GEICOgroup